Erin Garnett1, Julie Townsend2, Brooke Steele3, Meg Watson3. 1. Advanced Technology Logistics, Inc, Newnan, GA, USA. 2. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Hwy NE MS-F76, Atlanta, GA, 30341, USA. jtownsend@cdc.gov. 3. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Hwy NE MS-F76, Atlanta, GA, 30341, USA.
Abstract
PURPOSE: The purpose of this study is to describe the epidemiology of melanoma among Hispanics using data that cover nearly 100 % of the US population. METHODS: The study used population-based cancer incidence data from the National Program of Cancer Registries and the Surveillance, Epidemiology and End Results Program to examine melanoma incidence rates and trends among Hispanics by sex, age, race, histology, anatomic location, stage, and tumor thickness. RESULTS: From 2008 to 2012, 6,623 cases of melanoma were diagnosed among Hispanics. Rates were higher among males (4.6) than among females (4.0), but females younger than age 55 had higher rates than males. The most common histologic subtype was superficial spreading melanoma (23 %). Melanomas with poorer outcomes, such as nodular (NM) and acral lentiginous melanoma (ALM), were more common among males. Hispanic females had the highest proportion of melanoma on the lower limb and hip (33.7 %), while Hispanic males had the highest proportion on the trunk (29.9 %). Incidence rates for later-stage diagnosis and thicker tumors were significantly higher among Hispanic men than among women. Incidence rates decreased significantly during 2003-2012 (AAPC = -1.4). CONCLUSIONS: Clinicians and public health practitioners will need to reach the growing Hispanic population in the USA with strategies for primary prevention and early diagnosis of melanoma. Results suggest Hispanics and providers need education to increase awareness about the characteristics of melanoma among Hispanics, including types that occur on non-sun-exposed areas (ALM and NM). Skin cancer prevention and awareness interventions targeting Hispanics should be culturally relevant.
PURPOSE: The purpose of this study is to describe the epidemiology of melanoma among Hispanics using data that cover nearly 100 % of the US population. METHODS: The study used population-based cancer incidence data from the National Program of Cancer Registries and the Surveillance, Epidemiology and End Results Program to examine melanoma incidence rates and trends among Hispanics by sex, age, race, histology, anatomic location, stage, and tumor thickness. RESULTS: From 2008 to 2012, 6,623 cases of melanoma were diagnosed among Hispanics. Rates were higher among males (4.6) than among females (4.0), but females younger than age 55 had higher rates than males. The most common histologic subtype was superficial spreading melanoma (23 %). Melanomas with poorer outcomes, such as nodular (NM) and acral lentiginous melanoma (ALM), were more common among males. Hispanic females had the highest proportion of melanoma on the lower limb and hip (33.7 %), while Hispanic males had the highest proportion on the trunk (29.9 %). Incidence rates for later-stage diagnosis and thicker tumors were significantly higher among Hispanic men than among women. Incidence rates decreased significantly during 2003-2012 (AAPC = -1.4). CONCLUSIONS: Clinicians and public health practitioners will need to reach the growing Hispanic population in the USA with strategies for primary prevention and early diagnosis of melanoma. Results suggest Hispanics and providers need education to increase awareness about the characteristics of melanoma among Hispanics, including types that occur on non-sun-exposed areas (ALM and NM). Skin cancer prevention and awareness interventions targeting Hispanics should be culturally relevant.
Authors: Elliot J Coups; Jerod L Stapleton; Sharon L Manne; Shawna V Hudson; Amanda Medina-Forrester; Stephen A Rosenberg; Marsha Gordon; Kristina S Tatum; June K Robinson; Ana Natale-Pereira; James S Goydos Journal: J Behav Med Date: 2014-02-15
Authors: Kathleen K Thoburn; Robert R German; Mary Lewis; Phyllis Janie Nichols; Faruque Ahmed; Jeannette Jackson-Thompson Journal: Cancer Date: 2007-04-15 Impact factor: 6.860
Authors: Kirsten A M White; Yvonne T Dailey; Dolores D Guest; Kate Zielaskowski; Erika Robers; Andrew Sussman; Keith Hunley; Christopher R Hughes; Matthew R Schwartz; Kimberly A Kaphingst; David B Buller; Jennifer L Hay; Marianne Berwick Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-09-05 Impact factor: 4.254
Authors: A F Bais; R M Lucas; J F Bornman; C E Williamson; B Sulzberger; A T Austin; S R Wilson; A L Andrady; G Bernhard; R L McKenzie; P J Aucamp; S Madronich; R E Neale; S Yazar; A R Young; F R de Gruijl; M Norval; Y Takizawa; P W Barnes; T M Robson; S A Robinson; C L Ballaré; S D Flint; P J Neale; S Hylander; K C Rose; S-Å Wängberg; D-P Häder; R C Worrest; R G Zepp; N D Paul; R M Cory; K R Solomon; J Longstreth; K K Pandey; H H Redhwi; A Torikai; A M Heikkilä Journal: Photochem Photobiol Sci Date: 2018-02-14 Impact factor: 3.982
Authors: Laura Fejerman; Amelie G Ramirez; Anna María Nápoles; Scarlett Lin Gomez; Mariana C Stern Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-05-04 Impact factor: 4.090
Authors: Kimberly A Miller; Sarah E Piombo; Junhan Cho; Shauna Higgins; Ashley Wysong; Steve Sussman; Myles G Cockburn; Adam M Leventhal Journal: J Invest Dermatol Date: 2018-02-23 Impact factor: 8.551
Authors: Nancy L Asdigian; Anna E Barón; Joseph G Morelli; Stefan T Mokrohisky; Jenny Aalborg; Robert P Dellavalle; Matthew F Daley; Marianne Berwick; Keith E Muller; Neil F Box; Lori A Crane Journal: JAMA Dermatol Date: 2018-11-01 Impact factor: 10.282
Authors: Amelia K Smit; Marielys Collazo-Roman; Susan T Vadaparampil; Stella Valavanis; Jocelyn Del Rio; Brenda Soto; Idhaliz Flores; Julie Dutil; Peter A Kanetsky Journal: Sci Rep Date: 2020-04-29 Impact factor: 4.379